Terms and Conditions
Terms and Conditions
Effective Date: June 17, 2026
These Terms and Conditions (“Terms”) govern your access to and use of the TrialSphere Clinical Research website, including any pages, forms, study-interest submissions, event information, provider information, sponsor/CRO information, educational materials, and other website content made available through this site.
TrialSphere Clinical Research, formerly MD First Research Chandler, is a clinical research site located in Chandler, Arizona. The website is intended to provide general information about TrialSphere, clinical research opportunities, study participation, provider and sponsor/CRO collaboration, community education, events, and related services.
By accessing or using this website, you agree to these Terms. If you do not agree with these Terms, you should not use this website.
1. Website Information Only
The information on this website is provided for general informational and educational purposes only. Website content may describe clinical research, study opportunities, therapeutic areas, events, community education, provider relationships, sponsor/CRO relationships, and TrialSphere operations.
Website content does not constitute medical advice, diagnosis, treatment, a recommendation to participate in any clinical research study, or a substitute for professional medical judgment. You should consult your physician or qualified healthcare provider regarding any medical condition, treatment decision, study participation decision, or health-related question.
2. No Medical Advice or Emergency Use
This website is not intended for emergencies, urgent medical concerns, crisis situations, or time-sensitive healthcare needs.
Do not use this website, website forms, email, SMS/text messaging, or other website communication methods to report a medical emergency, urgent symptom, serious adverse event, or immediate safety concern. If you are experiencing a medical emergency, call 911 or seek emergency medical care immediately.
If you are currently participating in a clinical research study and have a study-related medical concern, adverse event, scheduling issue, medication question, or safety concern, follow the instructions provided in your informed consent form, study materials, study contact card, or other study-specific documentation.
3. Clinical Research Information and Study Participation
Information about clinical research studies on this website is provided for general awareness and preliminary inquiry purposes only. Study availability, eligibility criteria, enrollment status, procedures, compensation, study duration, visit requirements, risks, benefits, and other details may vary by study and may change over time.
Submitting an inquiry through this website does not enroll you in a clinical research study, guarantee eligibility, reserve a study position, create a participant relationship, or obligate TrialSphere to contact you or screen you for a study.
Participation in any clinical research study is voluntary and may require additional screening, eligibility review, informed consent, HIPAA authorization or other privacy authorization, IRB-approved materials, sponsor/CRO requirements, protocol-specific procedures, and study-specific documentation.
No person should participate in a clinical research study unless they have had the opportunity to review the applicable informed consent materials, ask questions, understand the potential risks and benefits, and voluntarily agree to participate in accordance with applicable legal, ethical, regulatory, IRB, sponsor/CRO, and protocol requirements.
4. Informed Consent and IRB Oversight
Website content does not replace, modify, supplement, or override any IRB-approved informed consent form, HIPAA authorization, participant-facing study document, recruitment material, protocol requirement, or sponsor/CRO-approved study material.
For studies requiring informed consent, consent must be obtained through the applicable study-specific process and documentation. The informed consent process may include review of the study purpose, procedures, risks, potential benefits, alternatives, privacy protections, compensation, costs, participant responsibilities, contact information, voluntary participation rights, withdrawal rights, and other required disclosures.
TrialSphere may conduct or support studies that are reviewed by an Institutional Review Board (“IRB”), Ethics Committee, sponsor, CRO, regulatory authority, or other oversight body, as applicable. Study-specific materials, recruitment content, consent forms, advertisements, and participant communications may be subject to IRB, sponsor/CRO, and regulatory review and approval.
If there is any conflict between this website and an IRB-approved informed consent form, HIPAA authorization, study protocol, sponsor/CRO instruction, regulatory requirement, or study-specific participant document, the applicable study-specific and regulatory documents control.
5. Privacy, Health Information, and HIPAA-Related Matters
TrialSphere respects the privacy of individuals who use this website or submit information through website forms. The collection, use, disclosure, retention, and protection of information submitted through this website are described in the TrialSphere Privacy Policy.
Information submitted through the website may include personal information, contact information, health-related information, study-interest information, referral information, or message content. Please do not submit Social Security numbers, financial account information, detailed medical records, emergency medical concerns, or highly sensitive information through general website forms unless specifically instructed by authorized TrialSphere personnel through an appropriate study-specific process.
Some health-related information collected or used in connection with clinical research may be subject to HIPAA, state privacy laws, informed consent documentation, HIPAA authorization forms, IRB waiver documentation, sponsor/CRO requirements, regulatory requirements, or other privacy and research compliance obligations.
Submitting information through a website form does not, by itself, create a provider-patient relationship, enroll you in a clinical research study, or complete any study-specific informed consent or HIPAA authorization process.
When feasible and appropriate, TrialSphere may use coded or unique study identification numbers rather than names or direct identifiers in study-related documentation, communications, tracking, and sponsor/CRO-facing materials. Directly identifying information is limited to authorized personnel and systems where needed for study operations, regulatory compliance, participant safety, required oversight, or legal obligations.
6. ClinicalTrials.gov and Public Study Information
Some clinical research studies may be registered on ClinicalTrials.gov or other public registries, as required or appropriate. Public registry information may include study title, condition, intervention, sponsor, study design, eligibility criteria, location information, recruitment status, outcomes, and other study-level information.
ClinicalTrials.gov and similar public registries are intended to provide public information about clinical studies. They are not a substitute for direct communication with the research team, study-specific screening, informed consent, HIPAA authorization, IRB-approved materials, or medical advice from a qualified healthcare provider.
TrialSphere does not control all information displayed on ClinicalTrials.gov or other third-party registries, sponsor websites, government websites, or external study listings. Public study listings may change over time and may not always reflect the most current site-level recruitment details, visit availability, scheduling availability, or operational status.
Participant-identifying information should not be included in public study registry records except as permitted or required under applicable law and public registry requirements.
7. Regulatory Compliance and Oversight
Clinical research may be subject to oversight by one or more regulatory or oversight entities, including but not limited to IRBs, Ethics Committees, the U.S. Food and Drug Administration (“FDA”), the U.S. Department of Health and Human Services (“HHS”), the Office for Human Research Protections (“OHRP”), sponsors, contract research organizations (“CROs”), monitors, auditors, institutional partners, and other applicable federal, state, local, or international authorities.
TrialSphere intends to conduct website communications, study inquiries, participant recruitment, study operations, and research-related activities in accordance with applicable laws, regulations, ethical standards, sponsor/CRO requirements, IRB requirements, protocol requirements, and good clinical practice expectations, as applicable.
Nothing on this website should be interpreted as changing or replacing any legal, regulatory, contractual, protocol-specific, sponsor/CRO, IRB, or participant-specific requirement.
8. SMS/Text Messaging and Phone Communications
If you provide your phone number, you may be contacted by TrialSphere by phone call, voicemail, or SMS/text message for purposes related to your inquiry, study opportunities, scheduling, follow-up communication, event participation, provider outreach, sponsor/CRO communication, or other TrialSphere-related operations.
Consent to receive SMS/text messages is not a condition of study participation or any purchase. Message frequency may vary. Message and data rates may apply. You may opt out of non-essential SMS/text communications by replying “STOP” where applicable or by contacting TrialSphere directly.
SMS/text messaging may not be fully secure. You should avoid sending sensitive medical information, emergency information, Social Security numbers, financial information, or detailed medical records by SMS/text message unless specifically instructed through an appropriate study-specific process.
TrialSphere does not sell phone numbers, SMS consent information, or text messaging opt-in data.
9. Email and Electronic Communications
If you provide your email address or contact TrialSphere by email, you consent to receive communications related to your inquiry, study opportunities, scheduling, events, provider or sponsor/CRO outreach, or TrialSphere operations.
Email may not be fully secure. You should avoid sending sensitive medical information, emergency information, Social Security numbers, financial information, or detailed medical records by general email unless specifically instructed through an appropriate study-specific process.
You may request that TrialSphere update your communication preferences, subject to study-specific, legal, regulatory, safety, recordkeeping, and operational requirements.
10. Website Forms and User-Submitted Information
You agree that information you submit through this website will be accurate to the best of your knowledge and that you will not submit false, misleading, fraudulent, abusive, unlawful, or unauthorized information.
You should only submit information about yourself unless you are authorized to submit information on behalf of another person. If you submit information on behalf of another person, you represent that you have appropriate authority or permission to do so.
TrialSphere may use submitted information to respond to inquiries, provide study-related information, conduct preliminary study-interest review, schedule follow-up communication, support clinical research operations, maintain records, comply with legal or regulatory obligations, and perform other activities described in the Privacy Policy.
TrialSphere is not required to respond to every inquiry, screen every person for every study, or provide access to any particular study, service, event, or opportunity.
11. Acceptable Website Use
You agree not to use this website for any unlawful, harmful, abusive, fraudulent, disruptive, or unauthorized purpose. Prohibited uses include, but are not limited to:
Attempting to gain unauthorized access to the website, systems, forms, data, accounts, servers, or networks;
Submitting false, misleading, fraudulent, or malicious information;
Uploading or transmitting viruses, malware, spam, or harmful code;
Interfering with website functionality, security, availability, or performance;
Scraping, copying, harvesting, or collecting website content or user information without authorization;
Misrepresenting your identity, affiliation, authority, eligibility, or purpose;
Using website content in a way that violates applicable law, regulation, intellectual property rights, privacy rights, or contractual obligations;
Using this website to report emergencies or urgent medical concerns.
TrialSphere may restrict access to the website, block submissions, remove content, preserve records, or take other action if misuse is suspected.
12. Intellectual Property
Unless otherwise noted, the content on this website, including text, graphics, logos, page layouts, icons, images, design elements, educational materials, downloadable materials, and other website content, is owned by or licensed to TrialSphere Clinical Research or its applicable partners.
You may view and print limited website content for personal, informational, non-commercial use only. You may not copy, reproduce, modify, publish, distribute, sell, display, create derivative works from, or commercially exploit website content without prior written permission from TrialSphere or the applicable rights holder.
Third-party logos, sponsor names, CRO names, study names, drug names, device names, government references, public registry references, and other third-party materials remain the property of their respective owners.
13. Third-Party Links and External Websites
This website may contain links to third-party websites, including sponsor websites, CRO websites, ClinicalTrials.gov, government websites, event websites, healthcare resources, partner websites, social media pages, video platforms, or other external resources.
Third-party links are provided for convenience and informational purposes only. TrialSphere does not control third-party websites and is not responsible for their content, availability, privacy practices, security practices, accuracy, advertising, policies, or terms of use.
Accessing a third-party website is at your own risk. You should review the privacy policies and terms of use for any third-party website you visit.
14. Study Availability, Content Accuracy, and Updates
TrialSphere makes reasonable efforts to maintain accurate and current website information. However, website content may contain errors, omissions, outdated information, typographical errors, or incomplete information.
Study information, recruitment status, eligibility criteria, locations, availability, compensation, visit schedules, procedures, sponsor/CRO information, event details, and other content may change without notice.
TrialSphere does not guarantee that website content is complete, current, accurate, uninterrupted, or error-free. TrialSphere may update, remove, replace, or modify website content at any time.
15. No Warranty
This website and its content are provided on an “as is” and “as available” basis. To the fullest extent permitted by law, TrialSphere disclaims all warranties, whether express, implied, statutory, or otherwise, including implied warranties of accuracy, completeness, reliability, merchantability, fitness for a particular purpose, non-infringement, security, availability, and uninterrupted operation.
TrialSphere does not warrant that the website will be error-free, secure, continuously available, free of viruses or harmful components, or compatible with every device, browser, or system.
16. Limitation of Liability
To the fullest extent permitted by law, TrialSphere Clinical Research, its owners, officers, directors, employees, contractors, investigators, research staff, affiliates, partners, service providers, and representatives will not be liable for any indirect, incidental, consequential, special, exemplary, punitive, or similar damages arising from or related to your use of, or inability to use, this website.
This includes, but is not limited to, damages related to website errors, outdated information, interrupted access, unauthorized access, third-party links, missed communications, delayed responses, study unavailability, ineligibility for a study, or reliance on website content.
Nothing in these Terms is intended to limit liability where such limitation is prohibited by applicable law.
17. Indemnification
You agree to defend, indemnify, and hold harmless TrialSphere Clinical Research, its owners, officers, directors, employees, contractors, investigators, research staff, affiliates, partners, service providers, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses, including reasonable attorneys’ fees, arising out of or related to your misuse of the website, violation of these Terms, violation of applicable law, submission of false or unauthorized information, or infringement of any rights of another person or entity.
18. Children’s Use of the Website
This website is not directed to children. Children should not submit information through this website without involvement and consent from a parent or legal guardian.
Some clinical research studies may involve minors only when permitted by applicable law, IRB approval, sponsor/CRO requirements, protocol requirements, parental permission, assent requirements, and study-specific informed consent procedures.
19. Relationship to Privacy Policy and Study Documents
These Terms should be read together with the TrialSphere Privacy Policy. The Privacy Policy explains how information submitted through the website may be collected, used, disclosed, protected, and retained.
For individuals who participate in a clinical research study, study-specific documents may also apply. These may include informed consent forms, HIPAA authorization forms, IRB-approved materials, recruitment materials, participant instructions, study contact information, sponsor/CRO materials, and protocol-specific documents.
If there is a conflict between these Terms and a study-specific informed consent form, HIPAA authorization, IRB-approved material, sponsor/CRO requirement, protocol requirement, or applicable law, the study-specific document or legal/regulatory requirement controls.
20. Governing Law
These Terms are governed by the laws of the State of Arizona, without regard to conflict-of-law principles, except where federal law or other applicable law controls.
Any dispute arising from or related to this website or these Terms will be handled in the appropriate state or federal courts located in Arizona, unless another venue is required by applicable law.
21. Changes to These Terms
TrialSphere may update these Terms from time to time to reflect changes in website functionality, clinical research operations, legal requirements, regulatory expectations, privacy practices, study operations, or business needs.
When updates are made, the effective date will be revised. Your continued use of the website after updated Terms are posted means you accept the updated Terms.
22. Contact Us
If you have questions about these Terms, this website, privacy practices, communication preferences, or TrialSphere’s clinical research website content, contact TrialSphere Clinical Research:
TrialSphere Clinical Research
3190 South Gilbert Road, Suite 5
Chandler, AZ 85286
Phone: (623) 267-8314
Email: ClinicalTrials@TrialSphereAZ.com
For study-specific questions, please refer to the applicable informed consent form, HIPAA authorization, study contact information, or research team instructions.
